Biogen (BIIB)

SG&A Expense Growth

16.86%

Quarterly · Period ending:

BIIB logo

BIIB SG&A Expense Growth

Latest reported16.86%
BIIB Quarterly SG&A Growth (QoQ) (0.00% → 16.86%)
High-resolution chart · PNG

BIIB sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
16.8615%
-11.0835%
14.8285%
2.3224%
1.166%
-15.3381%
17.646%
4.8337%
-4.8418%
-4.9005%
-19.2108%
40.2982%
-11.3223%
-5.2021%
13.2966%
-1.6242%
-9.8126%
-20.5581%
22.1832%
2.6361%
7.1092%
-26.8323%
41.895%
3.2427%
-2.6311%
-15.1005%
21.1001%
-2.5826%
0.2642%
-4.4115%
19.3289%
-3.5839%
2.9723%
-9.6431%
27.893%
0.9307%
-13.8159%
0.6458%
7.0888%
-6.0317%
-0.9853%
-14.6998%
22.0176%
-2.8664%
-12.2234%
-2.2958%
0.5491%
-1.0728%
12.6932%
3.2315%
22.2082%
-5.8996%
22.2389%
-6.2182%
25.48%
-0.7078%
0.5592%
-16.028%
4.2275%
-3.2392%
10.974%
-7.2377%
11.7063%
-5.1884%
4.0974%
2.3961%
6.0751%
6.4767%
2.0272%
14.5651%
-16.4259%
-0.9892%
17.6546%
22.4565%
1.6187%
-6.3947%
8.2989%
-2.1708%
10.8347%
1.8516%
10.2972%
-8.7097%
4.7773%
3.6314%
-1.7151%
-10.265%
33.1604%
-4.8718%
6.3742%
228.0471%
-476.8936%
2.5334%
24.1027%
-75.298%
18.9302%
-20.6636%
24.7677%
7.8995%
12.8857%
9.1757%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.